Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
OKYO
OKYO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OKYO News
OKYO Pharma to Present Urcosimod Data at ARVO 2026
Feb 23 2026
Newsfilter
Wall Street Analysts Adjust Ratings
Feb 20 2026
Benzinga
OKYO Pharma Prices Public Offering at $1.85 per Share
Feb 13 2026
NASDAQ.COM
OKYO Pharma Announces Public Offering of Shares
Feb 13 2026
seekingalpha
OKYO Pharma Prices Public Offering at $1.85 per Share
Feb 13 2026
Newsfilter
OKYO Pharma Transitions ATM Facility to Leerink Partners
Feb 11 2026
Newsfilter
OKYO Pharma to Present Urcosimod Data at ASCRS Meeting
Jan 30 2026
Newsfilter
OKYO Pharma Achieves Successful FDA Meeting on Urcosimod
Jan 28 2026
Newsfilter
OKYO Pharma (OKYO) Receives FDA Approval for Expanded Access of Urcosimod
Jan 23 2026
NASDAQ.COM
OKYO Pharma Appoints Robert Dempsey as CEO to Drive Growth
Jan 05 2026
NASDAQ.COM
OKYO Pharma Appoints Dempsey as CEO to Drive New Drug Development
Jan 05 2026
Globenewswire
OKYO Pharma Appoints New CEO to Drive Drug Development
Jan 05 2026
Newsfilter
GH Research (GHRS) Stock Surges 22.36% Ahead of Key Update
Jan 05 2026
NASDAQ.COM
OKYO Pharma Rings Nasdaq Opening Bell Celebrating Urcosimod Progress
Dec 19 2025
Globenewswire
OKYO Pharma Rings Nasdaq Opening Bell Celebrating Urcosimod Advancements
Dec 19 2025
Newsfilter
OKYO Pharma Completes NCP Trial and Sees Shareholder Increase
Dec 03 2025
Globenewswire
Show More News
